1. Home
  2. AQB vs FEED Comparison

AQB vs FEED Comparison

Compare AQB & FEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AquaBounty Technologies Inc.

AQB

AquaBounty Technologies Inc.

HOLD

Current Price

$0.95

Market Cap

4.8M

Sector

N/A

ML Signal

HOLD

FEED

ENvue Medical Inc. Common Stock

N/A

Current Price

$0.84

Market Cap

5.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AQB
FEED
Founded
1991
2003
Country
United States
United States
Employees
N/A
14
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
5.6M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
AQB
FEED
Price
$0.95
$0.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.7K
571.5K
Earning Date
05-14-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
87.66
N/A
EPS
N/A
N/A
Revenue
$2,472,659.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.70
$0.72
52 Week High
$2.95
$6.09

Technical Indicators

Market Signals
Indicator
AQB
FEED
Relative Strength Index (RSI) 54.71 37.46
Support Level $0.86 $0.84
Resistance Level $1.02 $0.97
Average True Range (ATR) 0.05 0.09
MACD -0.00 0.02
Stochastic Oscillator 41.95 41.11

Price Performance

Historical Comparison
AQB
FEED

About AQB AquaBounty Technologies Inc.

AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.

About FEED ENvue Medical Inc. Common Stock

ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes.

Share on Social Networks: